765302-70-3

Basic information

• Product Name: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester
• Synonyms: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester
• CAS NO: 765302-70-3
• Molecular Weight: 214.649
• Mol File: 765302-70-3.mol

Chemical Properties

• CAS DataBase Reference: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester(765302-70-3)
• EPA Substance Registry System: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester(765302-70-3)

Safety Data

• Hazardous Substances Data: 765302-70-3(Hazardous Substances Data)

Upstream product

• 1056987-17-7 ethyl 4-chloro-3-methoxyphenylacetate 
• 60397-70-8 2-(4-chloro-3-hydroxyphenyl)acetic acid 
• 64-17-5 ethanol 
• 867366-60-7 ethyl 4-chloro-3-methoxyphenylmethylimidate hydrochloride 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
• 73909-16-7 2-chloro-5-methylanisole 

Downstream Products

• 770718-63-3 C₁₄H₁₉ClO₃ 
• 770719-26-1 C₁₄H₁₉ClO₅ 
• 765302-71-4 ethyl 4-chloro-3-(3-cyano-5-fluorophenoxy)phenylacetate 
• 770719-36-3 C₁₇H₁₃Cl₂NO₃ 
• 928017-72-5 C₂₄H₂₆Cl₂N₂O₃S 
• 934241-70-0 ethyl {4-chloro-3-[2-chloro-4-(methylsulfonyl)phenoxy]phenyl}acetate 
• 1056155-67-9 C₁₉H₁₈ClNO₃ 
• 770718-74-6 C₁₆H₁₅Cl₂NO₃ 
• 770718-72-4 C₁₆H₁₂Cl₂N₂O₃ 

Relevant articles and documents

ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.

CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.

Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease

The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory-disorders, pharmaceutical compositions containing them, and processes for their preparation.

NOVEL COMPOUNDS

The invention relates to substituted phenylacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

Non-nucleoside reverse transcriptase inhibitors

The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1-R5, R7a, R7b, R7c, R8-R10, X1, X2 m, n, o and p are as defined herein.

Methods for treating retroviral infections

The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1-R5, R11c and X1 are as defined herein.